Arthramid
Clinical Research
& Studies

Peer-reviewed research on 2.5% iPAAG — equine, canine, and human joint health applications.

Published Research on Arthramid 2.5% iPAAG

Arthramid 2.5% iPAAG has been investigated across multiple peer-reviewed studies relating to equine and canine joint health, osteoarthritis management, synovial integration, and long-term clinical outcomes.

This research library brings together published studies, retrospective analyses, pre-clinical models, and clinical case applications across veterinary medicine.

Treatment Guides Contact

Research Areas Explored

The Arthramid® clinical research library brings together peer-reviewed studies exploring the use of 2.5% iPAAG across equine and canine joint health applications.

Research within this library includes:

  • equine joint health, lameness, and osteoarthritis management
  • synovial membrane integration and joint homeostasis
  • histological and biomechanical response following injection
  • safety, tolerability, and long-term clinical outcomes
  • canine osteoarthritis and emerging companion animal applications

The collection includes pre-clinical research, prospective clinical studies, retrospective analyses, and real-world veterinary case applications across multiple species and disciplines.

Arthramid White Papers

EQUINE WHITE PAPER

Veterinarians: Get your copy of our 24 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.

CANINE WHITE PAPER

Veterinarians: Get your copy of our 21 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.

Testimonials

Dr Dan Carter
Dr. Dan Carter
COUNTRYSIDE VETERINARY HOSPITAL - COVINGTON, GA
“Arthramid is a game changer for all equine athletes. It all starts in the synovium with synovitis and capsulitis, before we get to osteoarthritis. I routinely tell my horse owners, ‘save the synovium, save the joint’.”
Dr. Vern Dryden
BUR OAK SPORTS MEDICINE & LAMENESS, LEXINGTON, KY
“It’s given me another tool in my arsenal to effectively manage all stages of equine osteoarthritis, especially those horses with equine metabolic disease.”
Dr Marc Koene
TIERKLINIK LÜSCHE GMBH EQUINE HOSPITAL – NORTHER GERMANY
"We have injected over a thousand horses and have found it to be very safe. It has been a major game-changer in the way we treat OA in our patients.”
Dr CHarley McColough
Dr Charley McColough
PALM BEACH EQUINE - WELLINGTON, FL
"By incorporating Arthramid into my practice, I’m able to use far fewer steroids while still achieving excellent results, which gives me greater peace of mind for the long-term well-being of the horses under my care."
Dr Bob Peters
MCKINLAY & PETERS EQUINE HOSPITAL - NEWMAN LAKE, WA
"In my opinion, it is efficacious, long-lasting and lower risk to cartilage than many alternatives."
Testimonials

Get The White Paper

This field is for validation purposes and should be left unchanged.

Secret Link